Back
Phathom Pharmaceuticals Vs. Lixte Biotechnology Holdings Industry Stock Comparison
Buy
69
PHAT
Phathom Pharmaceuticals
Last Price:
$10.51
Seasonality Move:
13.25%
Sell
14
LIXT
Lixte Biotechnology Holdings
Last Price:
$1.12
Seasonality Move:
15.27%
Buy
69
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
-
The current Phathom Pharmaceuticals [PHAT] share price is $10.64. The Score for PHAT is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
PHAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
14
Lixte Biotechnology Holdings (LIXT)
is a Sell
Is Lixte Biotechnology Holdings a Buy, Sell or Hold?
-
The current Lixte Biotechnology Holdings [LIXT] share price is $1.11. The Score for LIXT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
LIXT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $10.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
LIXT Stock Price Chart
What is Lixte Biotechnology Holdings's stock price today?
-
The Lixte Biotechnology Holdings share price today is $1.11Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIXT is experiencing selling pressure, which indicates risk of future bearish movement.
PHAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.66 | Buy |
Relative Strength Index (14 RSI): | 86.4 | Buy |
Chaikin Money Flow: | 1162834 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.11 - 8.17) | Buy |
Bollinger Bands (100): | (3.67 - 6.93) | Buy |
LIXT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 39.78 | Sell |
Chaikin Money Flow: | -6923 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.23 - 1.41) | Sell |
Bollinger Bands (100): | (1 - 1.88) | Sell |
PHAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.97 | Buy |
20-day SMA: | 6.19 | Buy |
50-day SMA: | 4.76 | Buy |
200-day SMA: | 9.19 | Buy |
8-day EMA: | 9 | Buy |
20-day EMA: | 6.98 | Buy |
50-day EMA: | 5.68 | Buy |
200-day EMA: | 7.53 | Buy |
LIXT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.26 | Sell |
20-day SMA: | 1.29 | Sell |
50-day SMA: | 1.27 | Sell |
200-day SMA: | 1.7 | Sell |
8-day EMA: | 1.23 | Sell |
20-day EMA: | 1.28 | Sell |
50-day EMA: | 1.31 | Sell |
200-day EMA: | 1.7 | Sell |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.92 per share, an increase next quarter of $0.37 per share, an increase this year of $1.80 per share, and an increase next year of $2.44 per share.
Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Phathom Pharmaceuticals Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lixte Biotechnology Holdings Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |